| MolName | [2-oxo-2-[3-(3,4,5,6-tetrahydro-2H-azepin-7-ylsulfamoyl)anilino]ethyl] (E)-3-[3-(2-oxochromen-3-yl)-1-phenylpyrazol-4-yl]prop-2-enoate |
| MolecularFormula | C35H31N5O7S |
| Smiles | O=C(COC(/C=C/c1cn(-c2ccccc2)nc1C1=Cc(cccc2)c2OC1=O)=O)Nc1cccc(S(NC2=NCCCCC2)(=O)=O)c1 |
| InChI | InChI=1S/C35H31N5O7S/c41-32(37-26-11-9-14-28(21-26)48(44,45)39-31-16-5-2-8-19-36-31)23-46-33(42)18-17-25-22-40(27-12-3-1-4-13-27)38-34(25)29-20-24-10-6-7-15-30(24)47-35(29)43/h1,3-4,6-7,9-15,17-18,20-22H,2,5,8,16,19,23H2,(H,36,39)(H,37,41) |
| InChIK | NWTSNUBBHYHQAE-UHFFFAOYSA-N |
| TotalMolweight | 665.725 |
| Molweight | 665.725 |
| MonoisotopicMass | 665.19442 |
| CLogP | 2.9179 |
| CLogS | -5.688 |
| H Acceptors | 12 |
| H Donors | 2 |
| TotalSurfaceArea | 494.99 |
| Relative PSA | 0.28277 |
| PolarSurfaceArea | 166.43 |
| Druglikeness | -3.5865 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | low |
| Irritant | high |
| Nasty Functions | |
| Shape Index | 0.5 |
| Fragments | 1 |
| Non HAtoms | 48 |
| NonCHAtoms | 13 |
| Electronegative Atoms | 13 |
| Rotatable Bond | 9 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 23 |
| Sp3Atoms | 9 |
| Symmetricatoms | 3 |
| Amides | 2 |
| Aromatic Nitrogens | 2 |
| BasicNitrogens | 1 |
| StereoCon |
Click to Load Molecule:
1 - [2-oxo-2-[3-(3,4,5,6-tetrahydro-2H-azepin-7-ylsulfamoyl)anilino]ethyl] (E)-3-[3-(2-oxochromen-3-yl)-1-phenylpyrazol-4-yl]prop-2-enoate | 2 - [2-oxo-2-[3-(3,4,5,6-tetrahydro-2H-azepin-7-ylsulfamoyl)anilino]ethyl] (E)-3-[3-(2-oxochromen-3-yl)-1-phenylpyrazol-4-yl]prop-2-enoate